Laurion Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-332,189
| Closed | -$76.9K | – | 267 |
|
|
2024
Q3 | $76.9K | Sell |
332,189
-75,110
| -18% | -$17.4K | ﹤0.01% | 169 |
|
|
2024
Q2 | $221K | Sell |
407,299
-13,127
| -3% | -$7.14K | ﹤0.01% | 353 |
|
|
2024
Q1 | $429K | Sell |
420,426
-142,569
| -25% | -$145K | ﹤0.01% | 260 |
|
|
2023
Q4 | $321K | Sell |
562,995
-135,005
| -19% | -$77K | ﹤0.01% | 207 |
|
|
2023
Q3 | $726K | Hold |
698,000
| – | – | ﹤0.01% | 152 |
|
|
2023
Q2 | $984K | Hold |
698,000
| – | – | 0.01% | 144 |
|
|
2023
Q1 | $1.11M | Hold |
698,000
| – | – | 0.01% | 124 |
|
|
2022
Q4 | $1.02M | Hold |
698,000
| – | – | ﹤0.01% | 135 |
|
|
2022
Q3 | $2.98M | Hold |
698,000
| – | – | 0.02% | 110 |
|
|
2022
Q2 | $2.71M | Buy |
+698,000
| New | +$2.71M | 0.04% | 98 |
|